A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts

NCT03981822 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

105

Enrollment

INDUSTRY

Sponsor class

Conditions

Condylomata Acuminata
Papillomavirus Infections
Skin Diseases, Viral
Skin Diseases, Infectious
Skin Diseases
Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Warts

Interventions

COMBINATION_PRODUCT: VP-102 and applicator
COMBINATION_PRODUCT: Placebo

Sponsor

Verrica Pharmaceuticals Inc.

Collaborators

[object Object]
[object Object]
[object Object]